Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Extended iPrEx study looks at long-term safety, behavior change and medication adherence

In a conference call convened by AVAC Tuesday, government representatives, scientists and advocates discussed the particulars of the Pre-Exposure Prophylaxis Initiative (iPrEx) open label study set to launch at some trial sites in March 2011.

Published
09 February 2011
From
Science Speaks
What lies ahead for HIV prevention technologies in 2011?

This issue of Px Wire takes inventory of the regulatory, trial-planning and scientific agenda-setting steps that are being taken with respect to recent positive trial results. It reviews ongoing and proposed next steps that have been triggered by the Thai prime-boost AIDS vaccine trial; the CAPRISA 004 microbicide trial and the iPrEx trial of once-daily TDF/FTC for pre-exposure prophylaxis.

Published
12 January 2011
From
AVAC
Fenway Institute releases interim guidance for clinicians on pre-exposure prophylaxis

The Fenway Institute has issued preliminary guidance for medical providers on the use of pre-exposure prophylaxis (PrEP) as an HIV prevention tool.  

Published
31 December 2010
From
Fenway Health
Time magazine names HIV pre-exposure prophylaxis as number 1 medical breakthrough of 2010

Antiretroviral drugs have turned the AIDS epidemic around, by thwarting the virus in HIV-positive patients. But new research suggests that this powerful treatment may have another benefit — as a weapon against infection in healthy individuals.

Published
17 December 2010
From
Time
U.S. considers new tools in global AIDS fight

The U.S. global AIDS program may turn to new tools such as microbicide gels and pre-infection treatment to slow the epidemic in hard-hit countries, the program's director said on Tuesday.

Published
15 December 2010
From
Reuters
Drug to prevent HIV brings promise and questions

AIDS advocacy groups and public health leaders cheered the news from a study last month that an anti-retroviral drug used to treat HIV can also prevent infections - but it's a celebration complicated by questions of ethics and efficacy.

Published
09 December 2010
From
San Francisco Chronicle
HIV prevention drug: thanks, but no thanks

Charles Karel Boulay writes: I disapprove of a pill that would make healthy people customers of drug companies when all they have to do is take control of their bodies and lives.

Published
29 November 2010
From
Huffington Post
SOUTH AFRICA: HIV prevention drugs raise more questions than answers

JOHANNESBURG, 29 November 2010 (PLUSNEWS) - Recent studies have shown that antiretroviral [ARV] drugs can reduce the risk of HIV-infection but for researchers and governments - the research raises more questions than answers about its implementation.

Published
29 November 2010
From
IRIN Plus News
HIV Prevention: towards the medicalisation of sex?

2010 will be a year to remember for the field of HIV prevention. Two clinical studies are raising the hope that the HIV epidemic can be tamed. But only if we get it right.

Published
26 November 2010
From
Open Democracy
MSM groups hail pill to prevent HIV

NAIROBI: Gay rights groups have hailed the results of the first study to show that an antiretroviral (ARV) drug can prevent HIV as an important step in the fight against HIV, but say that in countries that criminalize homosexuality, the breakthrough is unlikely to have a significant impact.

Published
24 November 2010
From
Plus News

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.